Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

iCLAS™ for Persistent Atrial Fibrillation

NCT: NCT04061603 · COMPLETED

NCT IDNCT04061603
StatusCOMPLETED
Start Date2019-12-09
Completion2024-08-30

Brief Summary

Clinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS™) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)

Frequently Asked Questions

What is iCLAS™ for Persistent Atrial Fibrillation?

iCLAS™ for Persistent Atrial Fibrillation is a clinical trial registered under NCT04061603. Current status: COMPLETED.

What is the status of NCT04061603?

The current status of NCT04061603 (iCLAS™ for Persistent Atrial Fibrillation) is: COMPLETED.

When did iCLAS™ for Persistent Atrial Fibrillation start?

iCLAS™ for Persistent Atrial Fibrillation started on 2019-12-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑